|
|
Efficacy and Influencing Factors of Dorsal Root Ganglion Pulsed Radiofrequency Combined with Pregabalin in the Treatment of Postherpetic Neuralgia |
QIAN Zhiqiang, LI Chunming |
Department of Pain, the Third People's Hospital of Nantong, Nantong Jiangsu 226000 |
|
|
Abstract 【Objective】To investigate the efficacy of dorsal root ganglion pulsed radiofrequency combined with pregabalin in the treatment of postherpetic neuralgia (PHN) and identify related influencing factors.【Methods】A total of 90 patients with PHN, who were treated at the Third People's Hospital of Nantong between May 2020 and May 2023, were enrolled. All patients received dorsal root ganglion pulsed radiofrequency combined with pregabalin treatment. Pain intensity was assessed before and after treatment using the Visual Analog Scale (VAS), and inflammatory markers including calcitonin gene-related peptide (CGRP), β-endorphin (β-EP), and prostaglandin E2 (PGE2) were measured as well. After 6 months of follow-up, patients were divided into the effective group and the ineffective groups based on the treatment outcome. Clinical data were collected, and multivariate Logistic regression analysis was performed to determine the factors influencing the treatment efficacy.【Results】After treatment, VAS scores significantly decreased (P<0.05). Levels of CGRP and PGE2 were lower, while β-EP levels were higher compared to baseline before treatment (P<0.05). There were significant differences between the two groups in terms of age, disease duration, diabetes, antiviral treatment, and the duration of analgesic use (P<0.05). Multivariate analysis showed that age >65 years, disease duration >6 months, diabetes, and prolonged analgesic use (>2 weeks) were risk factors affecting treatment efficacy (P<0.05).【Conclusion】Dorsal root ganglion pulsed radiofrequency combined with pregabalin significantly alleviates pain and reduces inflammatory markers in patients with PHN. Key risk factors influencing treatment efficacy include age >65 years, disease duration >6 months, diabetes, and prolonged use of analgesics for more than 2 weeks.
|
Received: 19 December 2024
|
|
|
|
|
[1] 徐晓绘,陈付强,于洋,等. 背根神经节脉冲射频联合富血小板血浆注射治疗带状疱疹后神经痛的临床研究[J].中华疼痛学杂志,2022,18(2):194-201.
[2] 张思思,焦保良. 加巴喷丁联合背根神经节脉冲射频治疗带状疱疹后神经痛的临床疗效[J].医学综述,2022,28(7):1453.
[3] 胡柳生,王礼彬,胡琴琴,等. DSA引导背根神经节脉冲射频治疗颈段带状疱疹后神经痛的临床观察[J].中国医学创新,2019,16(28):134-137.
[4] 苏莉,苏向向. 脉冲射频联合普瑞巴林治疗带状疱疹后遗神经痛的效果观察[J].实用中西医结合临床,2024,24(3):29-31.
[5] 潘雪芹,王然,赵定亮,等. 3D打印导板在胸段带状疱疹后神经痛背根神经节脉冲射频治疗中的应用[J].中华医学杂志,2021,101(43):3542-3548.
[6] 带状疱疹后神经痛诊疗共识编写专家组. 带状疱疹后神经痛诊疗中国专家共识[J].中国疼痛医学杂志,2016,22(3):161-167.
[7] 梅群丽,张微,宋祖琪,等. 腕踝针联合针刺夹脊穴治疗带状疱疹后遗神经痛的疗效及对VAS评分影响[J].四川中医,2020,38(9):198-200.
[8] 李新巧,阚厚铭,徐元玙,等. 背根神经节脉冲射频联合银质针治疗带状疱疹后遗神经痛临床研究[J].现代中西医结合杂志,2021,30(36):4023-4029.
[9] 耿书涵,王然,赵定亮,等. 脉冲射频对老年胸段带状疱疹后神经痛患者不同疼痛表型的疗效及安全性分析[J].中华医学杂志,2024,104(25):2330-2335.
[10] 李丽梅,刘悦,张志利,等. 臭氧穴位注射联合背根神经节脉冲射频对带状疱疹后遗神经痛临床效果及红细胞沉降率、C反应蛋白、白细胞介素-6的影响[J].世界中西医结合杂志,2020,15(11):2116-2120.
[11] 王钦,宋建民,李妍,等. 脉冲射频胸背根神经节联合药物治疗老年重度带状疱疹后神经痛病人的镇痛效果及机制研究[J].实用老年医学,2022,36(3):261-264.
[12] 张学良,乔长峰,马苏杰,等. 背根神经节脉冲射频联合加巴喷丁对带状疱疹后神经痛的治疗效果[J].实用临床医药杂志,2023,27(13):61-64.
[13] 黄景妹,王萍,叶峻宏,等. 背根神经节脉冲射频联合普瑞巴林治疗老年胸段带状疱疹后神经痛的疗效及对血清相关因子水平的影响[J].中国老年学杂志,2023,43(15):3729-3732.
[14] 刘冰,李琳,高谦. CT引导下脉冲射频治疗带状疱疹后神经痛患者疗效及相关因素分析[J].中国医学计算机成像杂志,2024,30(5):604-609.
[15] 高谦,李宝福,刘冰,等. CT引导下脉冲射频联合神经阻滞治疗带状疱疹后神经痛的疗效影响因素分析[J].中华物理医学与康复杂志,2024,46(4):337-341. |
|
|
|